Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine effects on serotonergic system outgrowth by age
2009-011824-79Phase 4Terminated
- Sponsor
- Academic Medical Center
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) and anxiety disorder comparing Fluoxetine with Placebo (2 arms). Primary endpoints: Age dependency of fluoxetine effects on serotonergic system outgrowth and Age dependency of behavioral outcomes related to serotonin. Started May 2009; status: terminated.
02
Drugs
fluoxetine
03
Conditions
major depressive disorder (MDD)anxiety disorder
Beyond the preview
Go deeper on 2009-011824-79.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011824-79.